New Arthritis Drug Xeljanz Gets FDA Approval
avatar
Caprice_WebMD_Staff posted:
Nov. 6, 2012 -- The FDA has approved Pfizer's Xeljanz (tofacitinib), a first-of-its-kind treatment for rheumatoid arthritis .

Xeljanz is approved for use by patients not helped by methotrexate , the usual first treatment for RA. It's a pill taken twice a day.

Xeljanz is a type of drug called a Janus kinase or JAK inhibitor. Blocking JAK mutes the inflammation responses responsible for RA.
"Xeljanz provides a new treatment option for adults suffering from the debilitating disease of RA who have had a poor response to methotrexate," says Badrul Chowdhury, MD, PhD, the FDA's head of pulmonary, allergy , and rheumatology products.
We must let go of the life we have planned, so as to accept the one that is waiting for us. ~Joseph Campbell
Was this Helpful?
2 of 2 found this helpful
Reply
 
avatar
lex16420 responded:
@25k a year
 
avatar
xperky replied to lex16420's response:
Yikes